HEPATIC FIBROSIS MARKER INCREASED

HEPATIC FIBROSIS MARKER INCREASED was reported 30 times

HEPATIC FIBROSIS MARKER INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thyroid Hormone Receptor beta Agonist [EPC] 13 0.0057
1 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
2 Interleukin-17A Antagonist [EPC] 6 0.0002
3 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1 0.0001
4 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
5 Angiotensin Converting Enzyme Inhibitor [EPC] 7 0.0001
6 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
7 Progesterone [EPC] 1 0.0000
8 PCSK9 Inhibitor [EPC] 1 0.0000
9 Provitamin D2 Compound [EPC] 1 0.0000
10 Dietary Cholesterol Absorption Inhibitor [EPC] 3 0.0000
11 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
12 Thiazide-like Diuretic [EPC] 1 0.0000
13 Vitamin D [EPC] 6 0.0000
14 Vitamin B12 [EPC] 6 0.0000
15 Vitamin C [EPC] 6 0.0000
16 Platelet Aggregation Inhibitor [EPC] 8 0.0000
17 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
18 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
19 Purine Antimetabolite [EPC] 1 0.0000
20 Aminosalicylate [EPC] 1 0.0000
21 Antirheumatic Agent [EPC] 1 0.0000
22 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
23 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
24 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
25 alpha-Adrenergic Blocker [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 4 0.0000
27 beta-Adrenergic Blocker [EPC] 2 0.0000
28 Aldosterone Antagonist [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 8 0.0000
30 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
31 Estrogen [EPC] 1 0.0000
32 RANK Ligand Inhibitor [EPC] 1 0.0000
33 Thiazide Diuretic [EPC] 1 0.0000
34 Kinase Inhibitor [EPC] 2 0.0000
35 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
36 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
37 Benzodiazepine [EPC] 1 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 1 0.0000